Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-04-01 Sale | 2020-04-03 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 11,524 | $4.79 | $55,200 | 282,878 (Direct) | View |
2020-03-16 Sale | 2020-03-20 9:30 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 2,849 | $3.88 | $11,054 | 316,885 (Direct) | View |
2020-03-09 Sale | 2020-03-13 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 13,857 | $4.9779 | $68,978 | 319,734 (Direct) | View |
2020-02-25 Sale | 2020-02-28 9:32 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 9,147 | $6.43 | $58,815 | 333,591 (Direct) | View |
2019-12-23 Sale | 2020-01-03 5:18 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 4,517 | $10.84 | $48,958 | 235,421 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-06-10 Equity Swap | 2020-06-10 11:22 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 327,878 | $0 | 0 (Direct) | View |
2020-06-10 Option Award | 2020-06-10 11:22 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 45,000 | $0 | 0 (Direct) | View |
2020-06-10 Disposition | 2020-06-10 11:22 am | N/A 2026-02-24 | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 45,102 | $0 | 0 (Direct) | View |
2020-02-10 Option Award | 2020-02-14 9:28 pm | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 107,317 | $0 | 342,738 (Direct) | View |